Tolvaptan: Le Evidenze Cliniche Per Una Terapia di Rallentamento Della Progressione Nel Rene Policistico Autosomico Dominante
Abstract non disponibile
Main Author: | Riccardo Magistroni |
---|---|
Format: | Article |
Language: | Italian |
Published: |
AboutScience Srl
2017-05-01
|
Series: | Giornale di Clinica Nefrologia e Dialisi |
Subjects: | |
Online Access: | https://journals.aboutscience.eu/index.php/gcnd/article/view/660 |
Similar Items
-
10-Year Evaluation of Adherence and Satisfaction with Information about Tolvaptan in ADPKD: A Single-Center Pilot Study
by: Schirutschke H, et al.
Published: (2021-09-01) -
La ricerca oggi
by: Riccardo Magistroni
Published: (2013-07-01) -
Rene policistico autosomico dominante: nuovi aspetti terapeutici
by: R. Magistroni
Published: (2018-01-01) -
Case report: a thiazide diuretic to treat polyuria induced by tolvaptan
by: Bart J. Kramers, et al.
Published: (2018-07-01) -
Tolvaptan in the treatment of autosomal dominant polycystic kidney disease: patient selection and special considerations
by: Sans-Atxer L, et al.
Published: (2018-01-01)